Concepedia

Alan Hartford

AH

Statistics

Publications

10

Citations

403

H-Index

10

Active since

1996

Affiliations

AbbVie (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Roche (United Kingdom)

Biostatistical Consulting (United States)

Cytel (United States)

Alan Hartford is an author at AbbVie (United States) specializing in biostatistics, experimental design, and pharmacy.

Publications per year

1996–2023

10

Publications

10

Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans

Arthur Bergman, Gail Murphy, Joanne Burke et al. · The Journal of Clinical Pharmacology · 2004 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Consequences of misspecifying assumptions in nonlinear mixed effects models

Alan Hartford, Marie Davidian · Computational Statistics & Data Analysis · 2000 · 67 citations

Public Health, Biostatistics, Causal Inference +10

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension

Steve Vucic, Parvathi Menon, William Huynh et al. · EClinicalMedicine · 2023 · 61 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Geostatistical Methods for Incorporating Auxiliary Information in the Prediction of Spatial Variables

Carol A. Gotway, Alan Hartford · Journal of Agricultural Biological and Environmental Statistics · 1996 · 53 citations

Computing, Biostatistics, Geoinformatics +15

Pharmacokinetics of Montelukast in Asthmatic Patients 6 to 24 Months Old

Elizabeth Migoya, Gregory L. Kearns, Alan Hartford et al. · The Journal of Clinical Pharmacology · 2004 · 43 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

1–5 of 10